Evidence map›Paper›PMID 42239172›Full record

ArticlebioRxiv : the preprint server for biology2026

The retroelement-derived human protein PEG10 is a regulator of mRNA splicing in neurons.

A M Matthews, A M Whiteley

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

A M MatthewsDepartment of Biochemistry, University of Colorado Boulder, United States.ORCID 0009-0003-7021-0759
A M WhiteleyDepartment of Biochemistry, University of Colorado Boulder, United States.ORCID 0000-0002-4144-7605

Funding

Predoctoral Training Program in Signaling and Cellular Regulation INCLUDE Down Syndrome SupplementT32GM142607 · NIGMS · UNIVERSITY OF COLORADO · PI Sabrina Leigh Spencer, Tin Tin Su · 2021 to 2026
$3.6M
Investigation of UBQLN2 in neuronal dysfunction and ALS-FTDR01NS131660 · NINDS · UNIVERSITY OF COLORADO · PI Alexandra Whiteley · 2023 to 2026
$2.5M
Laser Scanning Confocal MicroscopeS10OD034320 · OD · UNIVERSITY OF COLORADO · PI DRAGAVON, JOSEPH · 2023 to 2023
$445k
NIGMS NIH HHS T32 GM142607NIH HHS S10 OD034320NINDS NIH HHS R01 NS131660
6 · The paper itself

Abstract

Retroelements, including retrotransposons, endogenous retroviruses, and their fragments, as well as rare co-opted or domesticated retroelements, can contribute to neurodegenerative disorders and aging through modulation of gene expression and induction of neuroinflammation. Paternally Expressed Gene 10 (PEG10) is a retroelement-derived human gene that has recently been identified as a putative driver of Amyotrophic Lateral Sclerosis (ALS) and Angelman's Syndrome. PEG10 has been reported to bind nucleic acid and undergoes a complex self-processing pathway that results in gene expression changes when the protein accumulates in cells. Here, we report that PEG10 has selectivity for binding U/G-rich RNAs and influences widespread gene expression changes. PEG10 overexpression mimics the loss of TDP-43 in broad changes to gene expression, including dysregulation of mRNA splicing pathways. Specific changes to mRNA splicing were largely unique between TDP-43 knockdown and PEG10 overexpression, as classic TDP-43 targets including

Indexed as

Amyotrophic Lateral Sclerosis (ALS)Domesticated retroelementGene regulationNeuregulin 3 (NRG3)Neurodegenerative diseaseNucleocapsidPaternally Expressed Gene 10 (PEG10)SplicingTAR DNA-binding protein 43 (TDP-43)Transposon

Identifiers

PMID42239172
PMCPMC13228445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.